Invention Grant
- Patent Title: EZH2 inhibitor combination therapies
-
Application No.: US16762388Application Date: 2018-11-09
-
Publication No.: US11529344B2Publication Date: 2022-12-20
- Inventor: Manfred Kraus , Pei-Pei Kung , Thomas Andrew Paul , Shikhar Sharma , Dominique Verhelle
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Zhigang Rao
- International Application: PCT/IB2018/058795 WO 20181109
- International Announcement: WO2019/097369 WO 20190523
- Main IPC: A61K31/4725
- IPC: A61K31/4725 ; A61P35/00 ; A61K33/243 ; A61K31/357 ; A61K31/4412 ; A61K31/4433 ; A61K31/4545 ; A61K31/496 ; A61K31/501 ; A61K31/5355 ; A61K39/395 ; A61K45/06
Abstract:
This invention relates to combination therapies comprising an EZH2 inhibitor and a chemotherapeutic agent, and associated pharmaceutical compositions, methods of treatment, and pharmaceutical uses.
Public/Granted literature
- US20200268740A1 EZH2 INHIBITOR COMBINATION THERAPIES Public/Granted day:2020-08-27
Information query
IPC分类:
